Cordant Inc’s Nu Skin NUS Stock Holding History

Cordant Inc’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22	Closed	-$1K	–	866
2022 Q1	$1K	Buy	+22	New	+$1.09K	﹤0.01%	1042

Other funds holding NUS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Cordant Inc's NUS Position: Q2 2022 in Review

Cordant Inc sold out of Nu Skin (NUS) in Q2 2022, closing a stake of 22 shares — an estimated $1K sold.

Cordant Inc first reported a position in NUS in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 222 funds tracked by Wall St. Rank hold NUS as of Q2 2022.

Cordant Inc reported no remaining Nu Skin position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 22 Nu Skin shares in Q2 2022, an estimated $1K.
Cordant Inc first reported a position in Nu Skin in Q1 2022 and held it in 1 quarter.
Cordant Inc's Nu Skin position peaked at $1K in Q1 2022.
222 funds tracked by Wall St. Rank held Nu Skin as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.